MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS?; UNIT, ELECTROSURGICAL, ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)

Model Number	M00553690
Medical Device Problem Codes	Failure to Advance (2524); Activation, Positioning or Separation Problem (2906); Positioning Problem (3009); Activation Failure (3270)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	08/22/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Block h6: imdrf impact code f2301 captures the reportable event of additional intervention required to address the puncture site, due to the risk of bile leakage following the puncture.Imdrf device code a15 captures the reportable event of stent partially deployed.Imdrf device code a1502 captures the reportable event of stent positioning issue.
Event or Problem Description
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was intended to be implanted transduodenal for drainage of the bile duct during an endoscopic ultrasound (eus) procedure performed on (b)(6) 2025.During the procedure, the distal flange failed to deploy.An attempt was made to reposition the stent within the duct and redeploy the distal flange, but it was unable to advance due to the opposite wall position.Reportedly, the stent would not deploy due to angle of puncture in bile duct.A guidewire was then placed through the delivery system to facilitate an exchange for a new stent, and the stent was removed partially deployed.The retrieved stent was ultimately deployed outside the patient, and the procedure was completed using another of the same device.There were no patient complications reported as a result of this event.
Additional Manufacturer Narrative
Corrected field: h6 (device codes) were corrected.Block h6: imdrf device code a150101 captures the reportable event of stent first flange failure to expand.Imdrf impact code f2301 captures the reportable event of additional intervention required to address the puncture site, due to the risk of bile leakage following the puncture.
Event or Problem Description
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was intended to be implanted transduodenal for drainage of the bile duct during an endoscopic ultrasound (eus) procedure performed on (b)(6) 2025.During the procedure, the distal flange failed to deploy.An attempt was made to reposition the stent within the duct and redeploy the distal flange, but it was unable to advance due to the opposite wall position.Reportedly, the stent would not deploy due to angle of puncture in bile duct.A guidewire was then placed through the delivery system to facilitate an exchange for a new stent, and the stent was removed partially deployed.The retrieved stent was ultimately deployed outside the patient, and the procedure was completed using another of the same device.There were no patient complications reported as a result of this event.
Event or Problem Description
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was intended to be implanted transduodenal for drainage of the bile duct during an endoscopic ultrasound (eus) procedure performed on (b)(6) 2025.During the procedure, the distal flange failed to deploy.An attempt was made to reposition the stent within the duct and redeploy the distal flange, but it was unable to advance due to the opposite wall position.Reportedly, the stent would not deploy due to angle of puncture in bile duct.A guidewire was then placed through the delivery system to facilitate an exchange for a new stent, and the stent was removed partially deployed.The retrieved stent was ultimately deployed outside the patient, and the procedure was completed using another of the same device.There were no patient complications reported as a result of this event.
Additional Manufacturer Narrative
Blocks h7, h9 and h11 have been updated.Block h6: imdrf device code a150101 captures the reportable event of stent first flange failure to expand.Imdrf impact code f2301 captures the reportable event of additional intervention required to address the puncture site, due to the risk of bile leakage following the puncture.Block h11: boston scientific is initiating a removal of certain sizes of the axios stent and electrocautery enhanced delivery system (6mm x 8mm, 8mm x 8mm and 20mm x 10mm) manufactured since march 1, 2025.This action is being taken due to increased reports of stent deployment and expansion issues with these configurations.These issues only occur at the time of stent delivery and are expected to be noticed by the physician.Patients who have been treated with a successfully implanted axios stent should continue to follow standard of care and are not affected by this issue.A letter was sent out to materials managers/health care professionals on 19-dec-2025 to immediately stop further distribution or use of any affected 6mm x 8mm, 8mm x 8mm and 20mm x 10mm axios stent and electrocautery enhanced delivery system.The letter indicates to remove these devices from inventory and segregate them in a secure location until they can be returned to boston scientific.The referenced axios stent and electrocautery enhanced delivery system met all specifications prior to final approval for distributions/sale.

• Brand Name: AXIOS?
• Common Device Name: UNIT, ELECTROSURGICAL, ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
• Manufacturer (Section D): BOSTON SCIENTIFIC CORPORATION; 300 boston scientific way; marlborough MA 01752
• Manufacturer (Section G): BOSTON SCIENTIFIC CORPORATION; ballybrit business park; galway ; EI
• Manufacturer Contact: christina lam ; 300 boston scientific way; marlborough, MA 01752 ; 9145716918
• MDR Report Key: 23069400
• Report Number: 3005099803-2025-04647
• Device Sequence Number: 15868765
• Product Code: KNS
• UDI-Device Identifier: 00191506008093
• UDI-Public: (01)00191506008093(17)261119(10)36573599
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• PMA/510(K) Number: K233318
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional,Company Representative
• Initial Reporter Occupation: Physician
• Remedial Action: Recall
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 01/13/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: M00553690
• Device Catalogue Number: M00553690
• Device Lot Number: 0036573599
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/22/2025
• Supplement Date Received by Manufacturer: 09/17/2025; 12/19/2025
• Initial Report FDA Received Date: 09/16/2025
• Supplement Report FDA Received Date: 10/10/2025; 01/13/2026
• Date Device Manufactured: 05/21/2025
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: 3005099803-12192025-004-
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Unknown